Judgment: Enhanced Damages On Past Sales

No definition available.

Name:	gild_JudgmentEnhancedDamagesOnPastSales
Namespace Prefix:	gild_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Judgment: Royalty Rate from October 2017

+ References

No definition available.

+ Details

Name:	gild_JudgmentRoyaltyRateFromOctober2017
Namespace Prefix:	gild_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Judgment: Royalty Rate on Future Sales

+ References

No definition available.

+ Details

Name:	gild_JudgmentRoyaltyRateOnFutureSales
Namespace Prefix:	gild_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Additional Patents Allegedly Infringed, Number

+ References

No definition available.

+ Details

Name:	gild_LossContingencyAdditionalPatentsAllegedlyInfringedNumber
Namespace Prefix:	gild_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Material Transfer Agreements, Number

+ References

No definition available.

+ Details

Name:	gild_LossContingencyMaterialTransferAgreementsNumber
Namespace Prefix:	gild_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number Of Patents

+ References

No definition available.

+ Details

Name:	gild_LossContingencyNumberOfPatents
Namespace Prefix:	gild_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Parties Appealed, Number

+ References

No definition available.

+ Details

Name:	gild_LossContingencyPartiesAppealedNumber
Namespace Prefix:	gild_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Patents Allegedly Infringed, Number, Scenario One

+ References

No definition available.

+ Details

Name:	gild_LossContingencyPatentsAllegedlyInfringedNumberScenarioOne
Namespace Prefix:	gild_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss Contingency, Patents Allegedly Infringed, Number, Scenario Two

+ References

No definition available.

+ Details

Name:	gild_LossContingencyPatentsAllegedlyInfringedNumberScenarioTwo
Namespace Prefix:	gild_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_LitigationReserve
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of damages awarded to the plaintiff in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349

+ Details

Name:	us-gaap_LossContingencyDamagesAwardedValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of plaintiffs that have filed claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of cash paid for the settlement of litigation or for other legal issues during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585

+ Details

Name:	us-gaap_PaymentsForLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=gild_JunoTherapeuticsIncAndSloanKetteringCancerCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=gild_PreExposureProphylaxisMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=gild_EuropeanPatentClaims2032ExpirationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=gild_ProductLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

COMMITMENTS AND CONTINGENCIES (Details)	1 Months Ended				9 Months Ended
COMMITMENTS AND CONTINGENCIES (Details)	Mar. 31, 2022 patent	Feb. 28, 2022 USD ($)	Oct. 31, 2021 patent	Dec. 31, 2019 USD ($) opposingParty patent	Sep. 30, 2022 USD ($) plaintiff lawsuit	Dec. 31, 2021 USD ($)	Apr. 30, 2020 agreement
Loss Contingencies [Line Items]
Accrued litigation \| $					$ 0	$ 1,250,000,000
Settlement payment \| $		$ 1,250,000,000
Number of patents challenged, scenario two				2
Number of patents challenged, scenario one				4
Number of additional patents allegedly infringed			2
Number of patents challenged	3
Number of patents	5
Juno Therapeutics, Inc. and Sloan Kettering Cancer Center
Loss Contingencies [Line Items]
Damages awarded \| $				$ 585,000,000
Running royalty rate from October 2017				27.60%
Enhancement rate on past damages							50.00%
Running royalty rate on future sales							27.60%
Pre-Exposure Prophylaxis
Loss Contingencies [Line Items]
Number of material transfer agreements \| agreement							4
European Patent Claims 2032 Expiration
Loss Contingencies [Line Items]
Number of parties appealed \| opposingParty				3
Product Liability
Loss Contingencies [Line Items]
Number of class action lawsuits \| lawsuit					1
Number of plaintiffs involved \| plaintiff					26,000